首页> 外国专利> SPIRO-SUBSTITUTED GLUTARAMIDE DIURETIC AGENTS

SPIRO-SUBSTITUTED GLUTARAMIDE DIURETIC AGENTS

机译:螺旋取代的谷氨酸利尿剂

摘要

Abstract"Spiro-Substituted Glutaramide Diuretic Agents"Compounds of the formula(I)wherein A completes a 4 to 7 membered carbocyclic ring which maybe saturated or mono-unsaturated and which may optionally be fusedto a further saturated or unsaturated 5 or 6 membered carbocyclicring; B is (CH2)m wherein m is an integer of from 1 to 3; each ofR and R4 is independently H, C1-C5 alkyl, benzyl or an alternativebiolabile ester-forming group; R1 is H or C1-C4 alkyl; R2 and R3are each independently H, OH, C1-C4 alkyl or C1-C4 alkoxy; and R5is C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, aryl(C2-C6 alkynyl),C3-C7 cycloalkyl, C3-C7 cycloalkenyl, C1-C6 alkoxy, -NR6R7,-NR8COR9, -NR9SO2R9 or a saturated heterocyclic group; or C1-C6alkyl substituted by one or more substituents chosen from halo,hydroxy, C1-C6 alkoxy, C2-C6 hydroxyalkoxy, C1-C6 alkoxy (C1-C6alkoxy), C3-C7 cycloalkyl, C3-C7 cycloalkenyl, aryl, aryloxy,aryloxy(C1-C4 alkoxy), heterocyclyl, heterocyclyloxy, -NR6R7,-NR8COR9, -NR8SO2R9, -CONR6R7, -SH, -S(O)pR10, -COR11 or -CO2R12;wherein R6 and R7 are2each independently H, C1-C4 alkyl, C3-C7 cycloalkyl (optionallysubstituted by hydroxy or C1-C4 alkoxy), aryl, aryl(C1-C4 alkyl),C2-C6 alkoxyalkyl, or heterocyclyl; or the two groups R6 and Rare taken together with the nitrogen to which they are attached toform a pyrrolidinyl, piperidino, morpholino, piperazinyl orN-(C1-C4 alkyl)piperazinyl group; R8 is H or C1-C4 alkyl; R9 isC1-C4 alkyl, CF3, aryl, aryl(C1-C4 alkyl), aryl(C1-C4 alkoxy),heterocycyl, C1-C4 alkoxy or NR6R7 wherein R6 and R7 are aspreviously defined; R10 is C1-C4 alkyl, aryl, heterocyclyl orNR6R7 wherein R6 and R7 are as previously defined; R11 is C1-C4alkyl, C3-C7 cycloalkyl, aryl or heterocyclyl; R12 is H or C1-C4alkyl; and p is 0, 1 or 2; and pharmaceutically acceptable saltsthereof and bioprecursors therefor are diuretic agents havingutility in the treatment of hypertension, heart failure, renalinsufficiency and in other disorders.
机译:抽象“螺取代的戊二酰胺利尿剂”式的化合物(一世)其中A完成一个4至7元碳环,是饱和的或单不饱和的,并且可以选择融合到另一个饱和或不饱和的5或6元碳环环; B为(CH 2)m,其中m为1至3的整数;每个R和R4独立地为H,C1-C5烷基,苄基或替代基团生物不稳定的成酯基团; R1是H或C1-C4烷基; R2和R3各自独立地为H,OH,C 1 -C 4烷基或C 1 -C 4烷氧基;和R5是C 1 -C 6烷基,C 2 -C 6烯基,C 2 -C 6炔基,芳基(C 2 -C 6炔基),C3-C7环烷基,C3-C7环烯基,C1-C6烷氧基,-NR6R7,-NR8COR9,-NR9SO2R9或饱和杂环基;或C1-C6被一个或多个选自卤素的取代基取代的烷基,羟基,C1-C6烷氧基,C2-C6羟基烷氧基,C1-C6烷氧基(C1-C6烷氧基),C3-C7环烷基,C3-C7环烯基,芳基,芳氧基,芳氧基(C1-C4烷氧基),杂环基,杂环氧基,-NR6R7,-NR8COR9,-NR8SO2R9,-CONR6R7,-SH,-S(O)pR10,-COR11或-CO2R12;其中R6和R7是2各自独立地为H,C1-C4烷基,C3-C7环烷基(可选被羟基或C1-C4烷氧基取代),芳基,芳基(C1-C4烷基),C 2 -C 6烷氧基烷基或杂环基;或两组R6和R与它们所附着的氮一起被带走形成吡咯烷基,哌啶子基,吗啉代,哌嗪基或N-(C1-C4烷基)哌嗪基; R8是H或C1-C4烷基; R9是C1-C4烷基,CF3,芳基,芳基(C1-C4烷基),芳基(C1-C4烷氧基),杂环基,C1-C4烷氧基或NR6R7,其中R6和R7为先前定义; R10是C1-C4烷基,芳基,杂环基或NR6R7其中R6和R7如前所定义; R11是C1-C4烷基,C 3 -C 7环烷基,芳基或杂环基; R12是H或C1-C4烷基; p为0、1或2;和药学上可接受的盐其及其生物前体是具有以下特征的利尿剂:可用于治疗高血压,心力衰竭,肾脏功能不足和其他疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号